Defining the mechanisms underlying Pelvic Radiotherapy Related Insufficiency Fractures

MRC · United Kingdom government procurement

GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

August 30, 2027
Response Due
Active
Status

Opportunity Overview

Radiotherapy is a type of cancer treatment using radiation. Every year, over 30,000 patients in the UK get this treatment for cancers in the pelvis, such as prostate, womb, bowel cancer. The good news is more people are surviving cancer because we are finding it early and treating it better.
But there is a problem. Cancer treatments, including radiotherapy, cause long-term health problems, which can be tough on patients and the NHS. Sometimes radiotherapy damages people's bones making them crack or break. This condition is called Radiotherapy-Related Insufficiency Fractures (RRIFs) and usually happens between 3 months and 3 years after radiotherapy. RRIFs can be very painful, make it hard for people to move around and reduce the quality of life.
We are not sure why RRIFs happen. We thought that radiotherapy causes osteoporosis (thinning of the bone) in the pelvis, making them easily breakable. However, I found that even people without bone thinning can get these fractures. Therefore, we need to dig deeper.
To understand why bones break after radiation, we have to study bones that have been treated with radiotherapy. But taking samples from people is risky because their bones are fragile. So, we use mice for our studies. Mouse bones work a lot like human bones, so they are a good model for our tests. Previous studies have tested radiotherapy on long bones, like the thigh bone. However, the structure of the pelvis is very different, and I believe that radiotherapy may have different effects there. My early research showed this might be true.
For this reason, I will study the impact of radiotherapy on the pelvis of mice in more detail. I will use a special machine that gives radiotherapy to mice in a similar way to that in humans. I will study the mouse bones at different times after treatment to see how they change and what makes them more fragile and prone to breaks. I will also check the effect of chemotherapy in addition to radiotherapy on bone, for the first...

This is one of 1,833 active United Kingdom Research Development opportunities most of your competitors will never see.

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyMRC
CountryUnited Kingdom
CategoryResearch Development
PublishedAugust 31, 2024
Procurement stageActive solicitation
Response dueAugust 30, 2027
StatusOpen — accepting responses
Official sourceView original notice
Last verifiedAugust 10, 2026

Source: UK Research and Innovation (UKRI) — Open Government Licence v3.0.

Related Opportunities in United Kingdom

Rotation year
Title of project: Evaluation of the quantitative accuracy and radiation dosimetry of an advanced pre-clinical multipinhole SPECT/CT theranostic imag
Discerning MCT1s role in chromatin remodelling and metabolomics changes in cancer progression
Leveraging real world data to characterise the long term impact of COVID-19
Bacterial antibiotic resistance: structure, mechanism and inhibition of ABC transporters responsible for drug efflux and cell wall biogenesis.
Characterising the role of TEX12 in centrosome and cilia development
Allogeneic Chondroprogenitor Therapy (Phase II) (ACT2)
Dectin-1-mediated suppression of protective anti-mycobacterial immunity

See every United Kingdom Research Development opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free United Kingdom Research Development intelligence report in your inbox

A personalized report on United Kingdom Research Development opportunities, emailed in 5-10 minutes. One per month, no account needed.